Plain-English translation of NCT06200987 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After prostate cancer surgery, many men experience erectile dysfunction and urinary incontinence — common side effects that can affect quality of life. This trial is testing whether a medical vibrator device used at home for 9 months can help prevent or reduce these problems. All participants will also receive standard medication to support sexual function.
Prostate cancer surgery can damage nerves and muscles that control erections and urinary control. Researchers want to see if early vibration therapy — started before or right after surgery — can protect sexual and urinary function better than standard treatment alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either use a vibrator device at home for 9 months or receive standard care only. If assigned to the vibrator group, you'll receive instruction on how to use the Ferticare 2.0 device before your surgery, then perform vibration therapy yourself at home. Both groups will receive standard medication for sexual function. You'll likely have follow-up visits and complete questionnaires about sexual function and urinary control over the 9-month period.
AI-generated summary from trial data · Sep 20, 2026 · Not medical advice
Denmark